englitazone has been researched along with glycogen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danbury, BH; Genereux, PE; Kreutter, DK; McPherson, RK; Stevenson, RW | 1 |
| Andrews, KM; Genereux, PE; Gibbs, EM; Herbst, JJ; Kreutter, DK; McPherson, RK; Persson, LM; Spitzer, J; Stevenson, RW; Swick, AG | 1 |
2 other study(ies) available for englitazone and glycogen
| Article | Year |
|---|---|
Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia.
Topics: Adipose Tissue; Animals; Benzopyrans; Biological Transport; Blood Glucose; Carbohydrate Metabolism; Drug Administration Schedule; Drug Synergism; Glucose Tolerance Test; Glycogen; Hexoses; Hypoglycemic Agents; Insulin; Lipid Metabolism; Male; Rats; Rats, Inbred Strains; Reference Values; Thiazoles; Thiazolidinediones; Time Factors | 1991 |
The antihyperglycemic agent englitazone prevents the defect in glucose transport in rats fed a high-fat diet.
Topics: Adipocytes; Animals; Benzopyrans; Biological Transport; Blood Glucose; Deoxyglucose; Dietary Carbohydrates; Dietary Fats; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Glycogen; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Male; Monosaccharide Transport Proteins; Muscle Proteins; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Wistar; Thiazoles; Thiazolidinediones | 1996 |